Stocks and Investing
Stocks and Investing
Fri, October 28, 2022
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Benjamin Budish Maintained (ARES) at Buy with Increased Target to $90 on, Oct 28th, 2022
Benjamin Budish of Barclays, Maintained "Ares Management Corporation" (ARES) at Buy with Increased Target from $80 to $90 on, Oct 28th, 2022.
Benjamin has made no other calls on ARES in the last 4 months.
There are 4 other peers that have a rating on ARES. Out of the 4 peers that are also analyzing ARES, 1 agrees with Benjamin's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Michael Cyprys of "Morgan Stanley" Maintained at Hold with Decreased Target to $76 on, Tuesday, July 19th, 2022
These are the ratings of the 3 analyists that currently disagree with Benjamin
- Adam Beatty of "UBS" Maintained at Strong Buy with Decreased Target to $78 on, Wednesday, October 19th, 2022
- Brent Dilts of "UBS" Maintained at Strong Buy with Increased Target to $82 on, Monday, August 1st, 2022
- Alexander Blostein of "Goldman Sachs" Maintained at Strong Buy with Decreased Target to $78 on, Wednesday, June 29th, 2022
Contributing Sources